BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8651169)

  • 1. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases.
    Solmi L; Primerano AM; Gandolfi L
    Am J Gastroenterol; 1996 Jun; 91(6):1189-94. PubMed ID: 8651169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
    Caturelli E; Bartolucci F; Biasini E; Vigliotti ML; Andriulli A; Siena DA; Attino V; Bisceglia M
    Am J Gastroenterol; 2002 Feb; 97(2):397-405. PubMed ID: 11866279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
    Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
    Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C.
    Gavilán JC; Ojeda G; Arnedo R; Puerta S
    Eur J Intern Med; 2013 Dec; 24(8):846-51. PubMed ID: 23849588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.
    Caturelli E; Solmi L; Anti M; Fusilli S; Roselli P; Andriulli A; Fornari F; Del Vecchio Blanco C; de Sio I
    Gut; 2004 Sep; 53(9):1356-62. PubMed ID: 15306600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early detection of hepatocellular carcinoma--high risk group and mass survey].
    Tanikawa K
    Gan To Kagaku Ryoho; 1993 May; 20(7):864-70. PubMed ID: 8387756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients.
    Caturelli E; Pompili M; Bartolucci F; Siena DA; Sperandeo M; Andriulli A; Bisceglia M
    Radiology; 2001 Aug; 220(2):337-42. PubMed ID: 11477234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseases.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Chiba T; Kanai F; Yokosuka O; Yamaguchi T
    J Gastroenterol Hepatol; 2014 Jan; 29(1):165-72. PubMed ID: 24224484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
    Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
    Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.
    Ren FY; Piao XX; Jin AL
    World J Gastroenterol; 2006 Aug; 12(29):4656-9. PubMed ID: 16937435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
    Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
    Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.